MIRTAZAPINE

Course overview

MIRTAZAPINE IS AN ATYPICAL ANTIDEPRESSANT AND IS USED PRIMARILY FOR THE TREATMENT OF A MAJOR DEPRESSIVE DISORDER. MIRTAZAPINE IS IN A GROUP OF TETRACYCLIC ANTIDEPRESSANTS (TECA). MIRTAZAPINE INHIBITS THE CENTRAL PRESYNAPTIC ALPHA-2-ADRENERGIC RECEPTORS, WHICH CAUSES AN INCREASED RELEASE OF SEROTONIN AND NOREPINEPHRINE. THE DRUG HAS SEDATIVE, ANTIEMETIC, ANXIOLYTIC, AND APPETITE STIMULANT EFFECTS, WHICH EXPLAINS ITS OFF-LABEL USE FOR INSOMNIA, PANIC DISORDER, POST-TRAUMATIC STRESS DISORDER, OBSESSIVE-COMPULSIVE DISORDER, GENERALIZED ANXIETY DISORDER, SOCIAL ANXIETY DISORDER, HEADACHES, AND MIGRAINES. THIS ACTIVITY WILL HIGHLIGHT THE MECHANISM OF ACTION, ADVERSE EVENT PROFILE, PHARMACOLOGY, MONITORING, AND RELEVANT INTERACTIONS OF MIRTAZAPINE, PERTINENT FOR INTERPROFESSIONAL TEAM MEMBERS IN TREATING PATIENTS WITH DEPRESSION WHERE IT IS OF CLINICAL VALUE.